Business Description
ACI Formulations Ltd
ISIN : BD0480ACIFL4
Description
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.06 | |||||
| Debt-to-EBITDA | 5.42 | |||||
| Interest Coverage | 3.45 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.15 | |||||
| Beneish M-Score | -1.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.1 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year EPS without NRI Growth Rate | 36.3 | |||||
| 3-Year Book Growth Rate | 8.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.55 | |||||
| 9-Day RSI | 46.48 | |||||
| 14-Day RSI | 47.69 | |||||
| 6-1 Month Momentum % | 2.32 | |||||
| 12-1 Month Momentum % | -20.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.24 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 174.71 | |||||
| Days Sales Outstanding | 139.73 | |||||
| Days Payable | 21.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.66 | |||||
| Dividend Payout Ratio | 0.35 | |||||
| 3-Year Dividend Growth Rate | -9.1 | |||||
| Forward Dividend Yield % | 1.66 | |||||
| 5-Year Yield-on-Cost % | 2.17 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.73 | |||||
| Operating Margin % | 16.01 | |||||
| Net Margin % | 8.74 | |||||
| FCF Margin % | -1.31 | |||||
| ROE % | 10.42 | |||||
| ROA % | 4.59 | |||||
| ROIC % | 7.19 | |||||
| ROC (Joel Greenblatt) % | 12.4 | |||||
| ROCE % | 17.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.96 | |||||
| PE Ratio without NRI | 16.96 | |||||
| Shiller PE Ratio | 23.02 | |||||
| PEG Ratio | 2.65 | |||||
| PS Ratio | 1.48 | |||||
| PB Ratio | 1.69 | |||||
| Price-to-Tangible-Book | 1.69 | |||||
| Price-to-Operating-Cash-Flow | 128.98 | |||||
| EV-to-EBIT | 14.34 | |||||
| EV-to-EBITDA | 13.58 | |||||
| EV-to-Revenue | 2.34 | |||||
| EV-to-FCF | -180.11 | |||||
| Price-to-Projected-FCF | 1.12 | |||||
| Price-to-DCF (Earnings Based) | 1.47 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.48 | |||||
| Price-to-Graham-Number | 1.02 | |||||
| Price-to-Net-Current-Asset-Value | 7.73 | |||||
| Earnings Yield (Greenblatt) % | 6.97 | |||||
| FCF Yield % | -0.88 | |||||
| Forward Rate of Return (Yacktman) % | 16.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ACI Formulations Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 3,833.966 | ||
| EPS (TTM) (BDT) | 7.09 | ||
| Beta | 0 | ||
| Volatility % | 33.11 | ||
| 14-Day RSI | 47.69 | ||
| 14-Day ATR (BDT) | 3.436731 | ||
| 20-Day SMA (BDT) | 121.67 | ||
| 12-1 Month Momentum % | -20.19 | ||
| 52-Week Range (BDT) | 107.5 - 159.8 | ||
| Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ACI Formulations Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ACI Formulations Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
ACI Formulations Ltd Frequently Asked Questions
What is ACI Formulations Ltd(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT120.30. The 52 week high of DHA:ACIFORMULA is BDT159.80 and 52 week low is BDT107.50.
When is next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA) is .
Does ACI Formulations Ltd(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.66% (As of Today), Highest Dividend Payout Ratio of ACI Formulations Ltd(DHA:ACIFORMULA) was 1.7. The lowest was 0.34. And the median was 0.58. The  Forward Dividend Yield % of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers